Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL.71, 2012, Pages

  Hinchcliff, Monique ^a   Desai, Chintan S ^a   Varga, John ^a   Shah, Sanjiv J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Diastolic dysfunction; Echocardiography; Mortality; Systemic sclerosis

Indexed keywords

ALBUMIN; BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN; NITROGEN; SODIUM; UREA;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART LEFT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; INTERSTITIAL LUNG DISEASE; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SEX DIFFERENCE; SYSTEMIC SCLEROSIS;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHICAGO; COMORBIDITY; DIASTOLE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SCLERODERMA, SYSTEMIC; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84864561549     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. CHAMPION HC: The heart in scleroderma. Rheum Dis Clin North Am 2008; 34: 181-90; viii.
2. ALLANORE Y, MEUNE C, KAHAN A: Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies. Curr Opin Rheumatol 2008; 20: 697-702.
3. FERRI C, GIUGGIOLI D, SEBASTIANI M, COLACI M, EMDIN M: Heart involvement and systemic sclerosis. Lupus 2005; 14: 702-7.
4. KAHAN A, COGHLAN G, MCLAUGHLIN V: Cardiac complications of systemic sclerosis. Rheumatology (Oxford) 2009; 48 (Suppl. 3): iii45-8.
5. MEUNE C, VIGNAUX O, KAHAN A, ALLANORE Y: Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies. Arch Cardiovasc Dis 2010; 103: 46-52.
6. STEEN V: The heart in systemic sclerosis. Curr Rheumatol Rep 2004; 6: 137-40.
7. MEDSGER TA, JR., MASI AT: Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 1973; 26: 647-60.
8. ALLANORE Y, MEUNE C, VONK MC et al.: Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010; 69: 218-21.
9. GULLULU S, KADERLI AA, EKBUL A et al.: Tissue Doppler echocardiography and myocardial performance index in patients with scleroderma. J Int Med Res 2005; 33: 417-24.
10. KEPEZ A, AKDOGAN A, SADE LE et al.: Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography 2008; 25: 191-7.
11. MEUNE C, ALLANORE Y, PASCAL O et al.: Myocardial contractility is early affected in systemic sclerosis: a tissue Doppler echocardiography study. Eur J Echocardiogr 2005; 6: 351-7.
12. MEUNE C, AVOUAC J, WAHBI K et al.: Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008; 58: 1803-9.
13. PLAZAK W, ZABINSKA-PLAZAK E, WOJASPELC A et al.: Heart structure and function in systemic sclerosis. Eur J Dermatol 2002; 12: 257-62.
14. ROSATO E, MAIONE S, VITARELLI A et al.: Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables. Rheumatol Int 2009; 29: 913-9.
15. DE GROOTE P, GRESSIN V, HACHULLA E et al.: Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 31-6.
16. NAGUEH SF, APPLETON CP, GILLEBERT TC et al.: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-33.17.
17. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
18. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
19. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
20. HOCHBERG MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
21. BOHAN A, PETER JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 344-7.
22. BOHAN A, PETER JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975; 292: 403-7.
23. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
24. GALIE N, HOEPER MM, HUMBERT M et al.: Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-537.
25. MCLAUGHLIN VV, ARCHER SL, BADESCH DB et al.: ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009; 119: 2250-94.
26. LANG RM, BIERIG M, DEVEREUX RB et al.: Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
27. HORTON KD, MEECE RW, HILL JC: Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. J Am Soc Echocardiogr 2009; 22: 776-92; quiz 861-2.
28. SOLOMON SD, JANARDHANAN R, VERMA A et al.: Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet 2007; 369: 2079-87.
29. ARMSTRONG GP, WHALLEY GA, DOUGHTY RN et al.: Left ventricular function in scleroderma. Br J Rheumatol 1996; 35: 983-8.
30. VALENTINI G, VITALE DF, GIUNTA A et al.: Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996; 55: 455-60.
31. CAN I, ONAT AM, AYTEMIR K et al.: Detecting subclinical biventricular impairment in scleroderma patients by use of pulsed-wave tissue Doppler imaging. Tex Heart Inst J 2009; 36: 31-7.
32. DESWAL A, FOLLANSBEE WP: Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996; 22: 841-60.
33. AKRAM MR, HANDLER CE, WILLIAMS M et al.: Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006; 45: 1395-8.
34. OHARA T, LITTLE WC: Evolving focus on diastolic dysfunction in patients with coronary artery disease. Curr Opin Cardiol 2010; 25: 613-21.